Fisher & Paykel Healthcare Corporation Limited (FPH.AX)
AUD 33.88
(-1.83%)
AUD 33.88
(-1.83%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 522.6 Million NZD | 23.77% |
| 2023 | 422.21 Million NZD | 6.68% |
| 2022 | 395.79 Million NZD | -22.32% |
| 2021 | 509.5 Million NZD | 14.05% |
| 2020 | 446.73 Million NZD | 58.54% |
| 2019 | 281.78 Million NZD | 13.62% |
| 2018 | 248 Million NZD | 24.97% |
| 2017 | 198.45 Million NZD | -2.34% |
| 2016 | 203.19 Million NZD | 2.3% |
| 2015 | 198.62 Million NZD | -11.41% |
| 2014 | 224.2 Million NZD | -9.0% |
| 2013 | 246.36 Million NZD | 10.03% |
| 2012 | 223.9 Million NZD | 9.59% |
| 2011 | 204.31 Million NZD | 12.33% |
| 2010 | 181.89 Million NZD | -13.15% |
| 2009 | 209.43 Million NZD | 53.99% |
| 2008 | 136 Million NZD | 67.59% |
| 2007 | 81.15 Million NZD | 27.85% |
| 2006 | 63.47 Million NZD | 65.83% |
| 2005 | 38.27 Million NZD | 16.18% |
| 2004 | 32.94 Million NZD | -8.31% |
| 2003 | 35.93 Million NZD | -17.3% |
| 2002 | 43.45 Million NZD | -48.64% |
| 2001 | 84.59 Million NZD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 594.9 Million NZD | 0.0% |
| 2024 FY | 522.6 Million NZD | 23.77% |
| 2024 Q4 | 522.6 Million NZD | 0.0% |
| 2023 Q4 | 451.1 Million NZD | 0.0% |
| 2023 Q2 | 538.86 Million NZD | 0.0% |
| 2023 FY | 422.21 Million NZD | 6.68% |
| 2022 Q4 | 427.3 Million NZD | 0.0% |
| 2022 Q2 | 434.41 Million NZD | 0.0% |
| 2022 FY | 395.79 Million NZD | -22.32% |
| 2021 FY | 509.5 Million NZD | 14.05% |
| 2021 Q2 | 377.76 Million NZD | 0.0% |
| 2021 Q4 | 554.1 Million NZD | 0.0% |
| 2020 Q4 | 461.2 Million NZD | 0.0% |
| 2020 Q2 | 311.99 Million NZD | 0.0% |
| 2020 FY | 446.73 Million NZD | 58.54% |
| 2019 Q2 | 245.15 Million NZD | 0.0% |
| 2019 FY | 281.78 Million NZD | 13.62% |
| 2019 Q4 | 293.5 Million NZD | 0.0% |
| 2018 FY | 248 Million NZD | 24.97% |
| 2018 Q2 | 246.6 Million NZD | 0.0% |
| 2018 Q4 | 263.7 Million NZD | 0.0% |
| 2017 Q4 | 216.6 Million NZD | 0.0% |
| 2017 FY | 198.45 Million NZD | -2.34% |
| 2017 Q2 | 215.01 Million NZD | 0.0% |
| 2016 Q2 | 287.41 Million NZD | 0.0% |
| 2016 FY | 203.19 Million NZD | 2.3% |
| 2016 Q4 | 225.13 Million NZD | 0.0% |
| 2015 Q2 | 211.58 Million NZD | 0.0% |
| 2015 Q4 | 198.62 Million NZD | 0.0% |
| 2015 FY | 198.62 Million NZD | -11.41% |
| 2014 Q4 | 224.2 Million NZD | 8.59% |
| 2014 Q3 | 206.47 Million NZD | -18.49% |
| 2014 FY | 224.2 Million NZD | -9.0% |
| 2014 Q1 | 214.06 Million NZD | -13.11% |
| 2014 Q2 | 253.3 Million NZD | 18.33% |
| 2013 Q3 | 195.9 Million NZD | -5.43% |
| 2013 Q2 | 207.14 Million NZD | 1.83% |
| 2013 Q1 | 203.42 Million NZD | -9.14% |
| 2013 Q4 | 246.36 Million NZD | 25.76% |
| 2013 FY | 246.36 Million NZD | 10.03% |
| 2012 FY | 223.9 Million NZD | 9.59% |
| 2012 Q4 | 223.9 Million NZD | 0.0% |
| 2011 FY | 204.31 Million NZD | 12.33% |
| 2011 Q4 | 204.31 Million NZD | 0.0% |
| 2010 FY | 181.89 Million NZD | -13.15% |
| 2010 Q4 | 181.89 Million NZD | 0.0% |
| 2009 Q4 | 209.43 Million NZD | 0.0% |
| 2009 FY | 209.43 Million NZD | 53.99% |
| 2008 Q4 | 136 Million NZD | 0.0% |
| 2008 FY | 136 Million NZD | 67.59% |
| 2007 Q4 | 81.15 Million NZD | 0.0% |
| 2007 FY | 81.15 Million NZD | 27.85% |
| 2006 Q4 | 63.47 Million NZD | 0.0% |
| 2006 FY | 63.47 Million NZD | 65.83% |
| 2005 Q4 | 38.27 Million NZD | 0.0% |
| 2005 FY | 38.27 Million NZD | 16.18% |
| 2004 Q4 | 32.94 Million NZD | 0.0% |
| 2004 FY | 32.94 Million NZD | -8.31% |
| 2003 Q4 | 35.93 Million NZD | 0.0% |
| 2003 FY | 35.93 Million NZD | -17.3% |
| 2002 FY | 43.45 Million NZD | -48.64% |
| 2001 FY | 84.59 Million NZD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Austco Healthcare Limited | 24.32 Million AUD | -2048.319% |
| Nanosonics Limited | 59.67 Million AUD | -775.758% |
| Osteopore Limited | 2.91 Million AUD | -17854.95% |
| SDI Limited | 46.68 Million AUD | -1019.369% |
| Trajan Group Holdings Limited | 85.14 Million AUD | -513.748% |